Shandong Science ›› 2023, Vol. 36 ›› Issue (2): 33-40.doi: 10.3976/j.issn.1002-4026.2023.02.005

• Pharmacology and Toxicology • Previous Articles     Next Articles

Study on the mechanism of Shiweiyipi Granules based on network pharmacology and molecular docking

LIU Wenwen1,2a(), LI Changgeng1,2a, KONG Na1,2a, LIU Shuang2a,2b, DONG Hongjing2a,2b,*()   

  1. 1. College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
    2. a. Shandong Analysis and Test Center; b. College of Pharmacy, Qilu University of Technology (Shandong Academy of Sciences), Jinan 250014, China
  • Received:2022-10-13 Published:2023-04-20 Online:2023-04-11

Abstract:

To investigate the major active ingredients and mechanism of Shiweiyipi Granules in treating spleen deficiency and food syndrome. With the help of related papers and the traditional Chinese medicine system pharmacology database and analysis platform, we obtained the major chemical compounds of 10 medicines from Shiweiyipi Granules in order to construct a chemical composition library. We also built a related target library using multiple databases. In addition, disease targets related to food accumulation and spleen strengthening were obtained from the Genecards, OMIM, and TTD databases. The chemical compositions-potential targets network was used to screen the key components and targets. The core components and targets were selected through the TCM-key components-key targets disease network; the core components were analyzed using the SwissADME database; and the CB Dock website was used for molecular docking. The results revealed that quercetin, poricoic acid A, poricoic acid C, and β-sitosterol were the core compounds of Shiweiyipi Granules, whereas CA2, PTGS1, and PTGS2 were the core targets of Shiweiyipi Granules. The molecular docking results showed that the core ingredients had a good affinity for the core targets. This study provided a theoretical basis and data support for further interpretation of the action mechanism and clinical application of Shiweiyipi Granules.

Key words: Shiweiyipi Granules, network pharmacology, molecular docking, mechanism, compounds

CLC Number: 

  • R285.5

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0